Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Completed Phase 2 Trials for Melphalan (DB01042)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01529827Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment